Berkeley Lights to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Berkeley Lights, a leader in digital cell biology, will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 15 to 17, 2022. Management is scheduled to present on February 16 at 9:00 a.m. PT / 12:00 p.m. ET. The conference is exclusive to BTIG clients. Berkeley Lights focuses on rapid development and commercialization of biotherapeutics and cell-based products through its advanced platform, which captures information from thousands of single cells. Forward-looking statements from the company carry inherent risks and uncertainties.
- None.
- None.
EMERYVILLE, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually from February 15 - 17, 2022.
Berkeley Lights management is scheduled to present on Wednesday, February 16 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time.
BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.
About Berkeley Lights
Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.
Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company’s growth and continual evolution see the statements in the "Risk Factors" sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.
Media Contact
Media@berkeleylights.com
Investor Contact
IR@berkeleylights.com
FAQ
When is Berkeley Lights presenting at the BTIG Conference?
What is the focus of Berkeley Lights' presentation at the conference?
Where can I listen to Berkeley Lights' presentation?
What is the role of Berkeley Lights in the biotech industry?
What are the risks associated with Berkeley Lights' forward-looking statements?
